| ABIOMED is a provider of temporary mechanical circulatory support devices and it provides a range of care to heart failure patients. Co. develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily performing the pumping function of the heart. Co.'s products include: the Impella 2.5 device, which is a percutaneous micro heart pump with an integrated motor and sensors; Impella CP, which primarily used by either interventional cardiologists; and Impella RP, a percutaneous catheter-based axial flow pump designed to allow more than four liters of flow per minute. We show 37 historical shares outstanding datapoints in our coverage of ABMD's shares outstanding history.|
Understanding the changing numbers of ABMD shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ABMD versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ABMD by allowing them to research ABMD shares outstanding history
as well as any other stock in our coverage universe.